The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy—a multicenter retrospective analysis
European Journal of Nuclear Medicine and Molecular Imaging2022Vol. 50(1), pp. 218–227
Citations Over TimeTop 10% of 2022 papers
Simon K. B. Spohn, Andrea Farolfi, Sarah Schandeler, Marco M. E. Vogel, Juri Ruf, Michael Mix, Simon Kirste, Francesco Ceci, Stefano Fanti, Helena Lanzafame, Francesca Serani, Christian Gratzke, August Sigle, Stephanie E. Combs, Denise Bernhardt, Juergen E. Gschwend, Josef A. Buchner, Christian Trapp, Claus Belka, Peter Bartenstein, Lena M. Unterrainer, Marcus Unterrainer, Matthias Eiber, Stephan G. Nekolla, Kilian Schiller, Anca-Ligia Grosu, Nina-Sophie Schmidt-Hegemann, Constantinos Zamboglou, Jan C. Peeken
Abstract
The non-invasive biomarker SUVmax can prognosticate outcome in patients undergoing sRT and recurrence confined to the prostatic fossa in PSMA-PET. Its addition might contribute to improve risk stratification of patients with recurrent PCa and to guide personalized treatment decisions in terms of treatment intensification or de-intensification. This article is part of the Topical Collection on Oncology-Genitourinary.
Related Papers
- → Influence of radical prostatectomy on miRNA dynamics in urine extracellular vesicles(2024)3 cited
- → A Cancer-Indicative microRNA Pattern in Normal Prostate Tissue(2013)17 cited
- → Prostate cancers detected on repeat prostate biopsies show spatial distributions that differ from those detected on the initial biopsies(2014)7 cited
- THE EXPRESSIONS OF MITOSIS REGULATIVE FACTOR STK-15 IN PROSTATE CANCER(2009)
- → Can we improve the detection rate of prostate cancer using standard 12‐core TRUS‐guided prostate biopsy? Focused on the location of prostate biopsy(2020)